Search clinical trials for: Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
Total 3469 results
-
Children's Memorial Health Institute, PolandDepartment of Internal Medicine, Hypertension and Vascular Diseases, The...Not yet recruitingGlucose 6 Phosphatase DeficiencyPoland
-
Nanfang Hospital, Southern Medical UniversityCompleted
-
Novo Nordisk A/SWithdrawn
-
Henrik Enghusen PoulsenUniversity of Copenhagen; University Hospital, Gentofte, CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
Novartis PharmaceuticalsCompletedRenal ImpairmentUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
University of MalayaUnknownNAFLD | Type2 DiabetesMalaysia
-
Joslin Diabetes CenterWithdrawnDiabetes, ObesityUnited States
-
Medical University of ViennaUnknownType 2 Diabetes | Metabolically Healthy ControlsAustria
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedHypertension | Cardiovascular Disease | Type 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Vietnam, Germany, Romania, Canada, Argentina, Slovakia, Taiwan, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, Israel, Mexico, South Africa
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedDiabetes Mellitus, Type 2 | Diabetic Ketoacidosis | Lower Extremity Amputation | UrosepsisCanada
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolTerminatedDiabetic NephropathiesSingapore
-
BayerActive, not recruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseJapan, Spain, Netherlands, United Kingdom, Denmark, United States
-
Boehringer IngelheimRecruitingKidney Disease, ChronicKorea, Republic of
-
The George InstituteMonash University; University of Sydney; The University of New South WalesRecruitingType 2 DiabetesAustralia
-
Icahn School of Medicine at Mount SinaiRecruitingHeart Failure With Reduced Ejection Fraction | CongestionUnited States
-
University of California, San FranciscoRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AgelessRxEnrolling by invitation
-
The University of Texas Health Science Center at...AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
University Health Network, TorontoMerck Sharp & Dohme LLC; University Medical Center Groningen; University of Toronto and other collaboratorsCompletedHeart Failure | Type 2 Diabetes MellitusNetherlands, Canada
-
Mansoura UniversityActive, not recruitingLupus Nephritis | SLE | SGLT2 InhibitorsEgypt
-
RWTH Aachen UniversityBoehringer IngelheimTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
National Medical Research Center for Cardiology...Ministry of Health of the Russian FederationCompletedDiabetes Mellitus, Type 2 | Heart Failure, DiastolicRussian Federation
-
AstraZenecaCompletedHeart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, Korea, Republic of, Brazil, Slovakia, Japan, South Africa, Sweden
-
Steno Diabetes Center CopenhagenNovo Nordisk A/S; Glostrup University Hospital, CopenhagenCompletedHypoxia | Type 1 Diabetes | Nephropathy | Autonomic Neuropathy, Diabetic | Mitochondrial AlterationDenmark
-
Novartis PharmaceuticalsCompletedElevated Body Mass IndexUnited States
-
Baylor College of MedicineTerminatedType 2 Diabetes MellitusUnited States
-
Hellenic Society for Medical EducationTerminated
-
University of DundeeAstraZeneca; NHS TaysideCompletedDoes Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? (DAPA-LVH)Type 2 Diabetes | Left Ventricular HypertrophyUnited Kingdom
-
Christopher BellAstraZenecaCompletedPhysical ActivityUnited States
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus | Renal Impairment
-
Hamad Medical CorporationUnknownMyocardial Infarction | PreDiabetes | CVD | T2DM (Type 2 Diabetes Mellitus)Qatar
-
University of Erlangen-Nürnberg Medical SchoolCompletedDiabetes Mellitus Type 2Germany
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States
-
Astellas Pharma IncCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHealthy | Diabetes Mellitus, Type 2United States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 1Canada
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Bioavailability of IpragliflozinUnited Kingdom
-
Astellas Pharma IncCompleted